Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Benign Monoclonal Gammopathies

cetylpyridinium chloride anhydrous has been researched along with Benign Monoclonal Gammopathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alder, H; Aqeilan, RI; Boccadoro, M; Croce, CM; Drandi, D; Garzon, R; Hagan, JP; Kuehl, M; Ladetto, M; Munker, R; Palumbo, A; Palumbo, T; Pichiorri, F; Suh, SS; Taccioli, C; Volinia, S; Zanesi, N1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Benign Monoclonal Gammopathies

ArticleYear
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Sep-02, Volume: 105, Issue:35

    Topics: Animals; Apoptosis Regulatory Proteins; Base Sequence; Bcl-2-Like Protein 11; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Health; Humans; Membrane Proteins; Mice; Mice, Nude; MicroRNAs; Molecular Sequence Data; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; p300-CBP Transcription Factors; Plasma Cells; Proto-Oncogene Proteins; Receptors, Interleukin-6; Repressor Proteins; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling Proteins; Tumor Suppressor Protein p53; Up-Regulation

2008